Popular on EntSun
- Female Motorsports Sponsorship & Expansion; Acquisition Agreement of UAE-Based Sports Incubator by Online Lottery & Sports Game Provider: Lottery.com - 231
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator - 213
- WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence - 211
- Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures - 205
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement - 163
- Let's Talk Series: At the Crossroads: Immigration Today - 152
- TEDxInglewood Returns to The Miracle Theater on August 9, 2025 — Celebrating Bold Ideas and Community Energy - 135
- Manhattan Boutique Real Estate Collaborates with InterContinental Hotels NYC in a Branding Partners Personalized Approach - 129
- Token-Operated Sake Service Opens at Tobu Nikko Station - 123
- JMC Princess Announces Release of Empowering New Single "PRETTY" – A Summer Anthem for Young Girls Everywhere - 121
Similar on EntSun
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
- New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
MMT NeuroTech Battles to Stop Alzheimer's Disease
EntSun News/10640098
Researchers seeking solutions to eliminate Alzheimer's disease (ALZ) before it even starts
RIDGEFIELD, Conn. - Oct. 15, 2015 - EntSun -- MMT Neurotech announced initial development of a clinical protocol for early identification and preventive treatment of pre-clinical Alzheimer's Disease (ALZ). Their new clinical trial protocol will verify two recent and very critical concepts in ALZ Clinical Research: that the development of Alzheimer's Disease can be predicted in individuals who do not have current memory impairment and that using preventative treatment in these individuals at risk for ALZ can stop development of the disease.
Dr. Donald Marks, founder and Chief Science Officer, explains the reasoning behind the plans: " There have been a number of attempts to treat Alzheimer's in the midst of the disease with limited success. While we must continue to develop drug therapies that will help existing patients, one of the most successful approaches to disease in medicine is prevention. With MMT's neuroimaging approaches to identify early brain changes, it is possible to predict the future development of ALZ in a cognitively normal but high risk individual at least 18-48 months before any symptoms of memory loss develop. We can then initiate early, preventative treatment for these cognitively normal individuals at high risk of developing ALZ, which may prevent progression to symptomatic cognitive impairment. "
More on EntSun News
MMT NeuroTech is collaborating with a non-profit health care group and an expanded group of physicians experienced in diagnosing and treating ALZ along with their experienced fMRI centers in the conduct of this protocol.
"Alzheimer's Disease is a devastating problem for individuals and their families", indicates Dr. Steven Levy, CEO of MMT Neurotech. "The number of ALZ patients is expected to grow 40% by 2025 with the total Americans with the disease projected to increase to 13.8 million. Many people do not know that 1 in 3 Seniors can expect to die of Alzheimer's Disease or another dementia- and the cost of caring for patients is expected to rise from $226 Billion to over $1 Trillion by 2050. MMT posits that prevention will be a vital tool in reducing the impact of ALZ. With their newest protocols, MMT believes it should be possible to prevent or slow the development of the disease. "
MMT Neurotech is commercializing neuroimaging for a number of clinical conditions including objectively documenting the presence of pain for personal injury cases and disability claims, establishing fibromyalgia, identifying depression and suicidal ideation, monitoring for deception or lie detection with greater than 90% accuracy, real-time memory recordings, as well as providing the earliest possible diagnosis and therefore treatment of Autism Spectrum Disorders and pre-Alzheimer's disease.
More on EntSun News
For more information about MMT.Neurotech and this study contact: Steven Levy MD SL@MilMag.net or Donald H. Marks MD PhD DHM@MilMag.net MMT NeuroTech www.MilMag.net is a New Jersey / Connecticut neurotechnology company which commercializes disruptive neuroimaging technologies to image thought.
Dr. Donald Marks, founder and Chief Science Officer, explains the reasoning behind the plans: " There have been a number of attempts to treat Alzheimer's in the midst of the disease with limited success. While we must continue to develop drug therapies that will help existing patients, one of the most successful approaches to disease in medicine is prevention. With MMT's neuroimaging approaches to identify early brain changes, it is possible to predict the future development of ALZ in a cognitively normal but high risk individual at least 18-48 months before any symptoms of memory loss develop. We can then initiate early, preventative treatment for these cognitively normal individuals at high risk of developing ALZ, which may prevent progression to symptomatic cognitive impairment. "
More on EntSun News
- BillBoards Inc. Hits the Road with God Bless America Tour and Reality Series Now Streaming on Tubi TV
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Slipaway Food Truck Park & Marina announces opening weekend July 4-6
- 16-Year-Old Entrepreneur Discovers All-Natural Skincare Breakthrough That Works in Just 48 Hours
MMT NeuroTech is collaborating with a non-profit health care group and an expanded group of physicians experienced in diagnosing and treating ALZ along with their experienced fMRI centers in the conduct of this protocol.
"Alzheimer's Disease is a devastating problem for individuals and their families", indicates Dr. Steven Levy, CEO of MMT Neurotech. "The number of ALZ patients is expected to grow 40% by 2025 with the total Americans with the disease projected to increase to 13.8 million. Many people do not know that 1 in 3 Seniors can expect to die of Alzheimer's Disease or another dementia- and the cost of caring for patients is expected to rise from $226 Billion to over $1 Trillion by 2050. MMT posits that prevention will be a vital tool in reducing the impact of ALZ. With their newest protocols, MMT believes it should be possible to prevent or slow the development of the disease. "
MMT Neurotech is commercializing neuroimaging for a number of clinical conditions including objectively documenting the presence of pain for personal injury cases and disability claims, establishing fibromyalgia, identifying depression and suicidal ideation, monitoring for deception or lie detection with greater than 90% accuracy, real-time memory recordings, as well as providing the earliest possible diagnosis and therefore treatment of Autism Spectrum Disorders and pre-Alzheimer's disease.
More on EntSun News
- Collision Course Concert Series Returns to Atlanta
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- BayView Entertainment, Inc. Releases Multi Award-Winning Horror Film 'The Forest Through the Trees'
- Germantown Fashion & Arts Festival 2025 Draws Thousands, Celebrates Creativity in Historic Philly
For more information about MMT.Neurotech and this study contact: Steven Levy MD SL@MilMag.net or Donald H. Marks MD PhD DHM@MilMag.net MMT NeuroTech www.MilMag.net is a New Jersey / Connecticut neurotechnology company which commercializes disruptive neuroimaging technologies to image thought.
Source: MMT Neurotech
0 Comments
Latest on EntSun News
- New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
- DimHum Launches Revolutionary CrowdShipping Service
- Eolian Signs New Information Exchange Agreement with the U.S. Department of Defense for Technology Innovation
- Jekale (JK) Debuts R-B Single "Jungle" Inspired by Fashion, Storytelling, and Self-Discovery
- Favorite Wedding Décor Ideas to Inspire Your Big Day: From Vision to Venue
- Infinite Health Introduces Cutting-Edge Regenerative Medicine for Wound Care with Trip Goolsby, MD
- Riser Music's LYKN Adds India, Mexico & U.s. Dates To "unleashed" World Tour
- A Theatrical Experience Like No Other: "A Praying Mama, A Rebellious Son" Comes August 30
- Prolific Hollywood Actor Phillip E. Walker-MFA is Experiencing His Best Year of Employment Ever
- Top Dentist Concord CA, Smile Makers Dental Care, Celebrates 500 5-Star Reviews
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- ALIVE and KICKING: LAUGHTER NEVER GETS OLD has its World Premiere July 11-20 in St. Charles, IL
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- Live Courageously Hosts Ann-Marie Murrell, Author, Journalist, Former Political Commentator
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- YYNOT Brings High-Energy RUSH Tribute to the Weinberg Center this September